Balyasny Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.9M | Buy |
152,727
+136,883
| +864% | +$39.3M | 0.07% | 292 |
|
|
2025
Q1 | $4.88M | Buy |
+15,844
| New | +$4.88M | 0.01% | 860 |
|
|
2024
Q1 | – | Sell |
-66,460
| Closed | -$14.6M | – | 2460 |
|
|
2023
Q4 | $14.6M | Sell |
66,460
-14,078
| -17% | -$3.1M | 0.03% | 536 |
|
|
2023
Q3 | $18.2M | Buy |
80,538
+39,968
| +99% | +$9.03M | 0.04% | 457 |
|
|
2023
Q2 | $8.96M | Sell |
40,570
-18,987
| -32% | -$4.19M | 0.02% | 636 |
|
|
2023
Q1 | $13.3M | Buy |
59,557
+14,819
| +33% | +$3.32M | 0.03% | 534 |
|
|
2022
Q4 | $12.4M | Sell |
44,738
-115,039
| -72% | -$32M | 0.03% | 521 |
|
|
2022
Q3 | $33.5M | Buy |
159,777
+55,173
| +53% | +$11.6M | 0.1% | 206 |
|
|
2022
Q2 | $24.6M | Buy |
+104,604
| New | +$24.6M | 0.08% | 291 |
|
|
2021
Q4 | – | Sell |
-9,918
| Closed | -$1.83M | – | 2331 |
|
|
2021
Q3 | $1.83M | Buy |
+9,918
| New | +$1.83M | 0.01% | 969 |
|
|
2021
Q2 | – | Sell |
-12,263
| Closed | -$2.05M | – | 2078 |
|
|
2021
Q1 | $2.05M | Buy |
12,263
+3,591
| +41% | +$601K | 0.01% | 847 |
|
|
2020
Q4 | $1.32M | Buy |
+8,672
| New | +$1.32M | 0.01% | 816 |
|
|
2019
Q4 | – | Sell |
-8,432
| Closed | -$672K | – | 1360 |
|
|
2019
Q3 | $672K | Sell |
8,432
-3,264
| -28% | -$260K | ﹤0.01% | 780 |
|
|
2019
Q2 | $913K | Buy |
+11,696
| New | +$913K | 0.01% | 967 |
|
|
2018
Q3 | – | Sell |
-4,860
| Closed | -$550K | – | 1781 |
|
|
2018
Q2 | $550K | Buy |
4,860
+453
| +10% | +$51.3K | ﹤0.01% | 1144 |
|
|
2018
Q1 | $495K | Buy |
+4,407
| New | +$495K | ﹤0.01% | 1261 |
|
|
2017
Q4 | – | Sell |
-3,200
| Closed | -$375K | – | 2018 |
|
|
2017
Q3 | $375K | Buy |
+3,200
| New | +$375K | ﹤0.01% | 1237 |
|
|
2017
Q2 | – | Sell |
-7,620
| Closed | -$1.03M | – | 1515 |
|
|
2017
Q1 | $1.03M | Buy |
+7,620
| New | +$1.03M | ﹤0.01% | 918 |
|
|
2016
Q1 | – | Sell |
-1,763
| Closed | -$276K | – | 1323 |
|
|
2015
Q4 | $276K | Buy |
+1,763
| New | +$276K | ﹤0.01% | 861 |
|